Apibestan 150-H apimed pharma treatment for primary hypertension (2 blisters x 14 tablets)
Dosage form Box of 2 blisters x 14 tablets
Specifications Irbesartan, hydrochlorothiazid
Ingredient APIMED Pharmaceutical Joint Stock Company - Vietnam
Ingredient
| Composition information | Content |
| Irbesartan | 150mg |
| Hydrochlorothiazid | 12.5mg |
Uses
indicated
Treatment of primary hypertension.
The combination of these fixed doses is indicated for hypertension patients who are not well controlled when treated with each monomer Irbesartan or hydrochlorothiazide.
Pharmacological
No data.
pharmacokinetics
No data.
Before taking Apibestan 150-H apimed pharma treatment for primary hypertension (2 blisters x 14 tablets)
How to use
Take oral use.
Dosage
Specific dose depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when using overdose?
What to do when forgetting a dose?
Side Effects
Notify the physician the unwanted effects when using the drug.
Warnings
Before using the drug you need to read the instructions carefully and refer to the information below.
Contraindicated
Apibestan 150 - H Contraindicated in the following cases:
There is a history of hypersensitivity to any component of the drug.
Caution when using
No data.
The effect of the drug on driving and operating machinery
No data.
Use drugs for women during pregnancy and lactation
No data.
Drug interaction
drug interactions can affect the activity of the drug or cause side effects.
Patients should notify the doctor or pharmacist a list of the drugs and functional foods you are using. Do not use or increase or decrease the dose of the drug without the guidance of a doctor.
Storage
Leave a cool place, avoid light, temperatures below 30⁰C.
To be out of reach of children, read the instructions carefully before use.
Other drugs
- MERONEM IV 1G
- Nivestim
- RADIAN MASSAGE CREAM
- SUSTANON 250 250MG/ML SOLUTION FOR INJECTION
- TERTROXIN TABLETS 20MCG
- UTROGESTAN CAPSULES 200MG
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions